J&J Stock Sinks After Revenue Misses and Full-year Outlook Was Cut, as Drug Sales Disappoint
Jason Ware, Partner & Chief Investment Officer at Albion Financial Group, talks about the growth prospects for the healthcare industry and highlights areas in the market that are undervalued.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.